Experiments for taxon Lindera obtusiloba (LAURACEAE)

98 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
249108	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	MATAIRESINOL,5-6-DIHYDROXY:
261172	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,CIS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHYL: (3S-4S):
1085671	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEMATOCIDAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249098	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	ACTIFOLIN
736709	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
1091666	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Lindera obtusiloba (LAURACEAE)
261166	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PENTA-2-4-DIEN-4-OLIDE,2-(1-METHOXY-11-DODECENYL):
249100	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lindera obtusiloba (LAURACEAE)	PLUVIATILOL
776212	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249120	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	LARICIRESINOL,9'-O-TRANS-FERULOYL-5'-DIMETHOXY: (+):
261177	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,TRANS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHOXY-4-METHYL: (3R-4R):
375661	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)
736699	VOUCHER SPECIMEN REPORTED FOR		Lindera obtusiloba (LAURACEAE)
776216	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249114	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	SYRINGARESINOL,(+):
736708	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249104	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PLUVIATILOL
736693	VOUCHER SPECIMEN REPORTED FOR		Lindera obtusiloba (LAURACEAE)
565188	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)
726802	VOUCHER SPECIMEN REPORTED FOR		Lindera obtusiloba (LAURACEAE)
249118	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	SYRINGARESINOL,(+):
1299909	PHARMACOLOGY OF EXTRACT - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Lindera obtusiloba (LAURACEAE)
736697	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
261171	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,CIS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHYL: (3S-4S):
261182	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,TRANS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHOXY-4-METHYL: (3R-4R):
813969	PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lindera obtusiloba (LAURACEAE)	OBTUSILACTONE C-19 DIMER
249097	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	ACTIFOLIN
375660	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	VERMIFUGE ACTIVITY	Lindera obtusiloba (LAURACEAE)
736702	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
261167	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PENTA-2-4-DIEN-4-OLIDE,2-(1-METHOXY-11-DODECENYL):
325505	PMR SPECTRUM REPORTEDCHEMICAL CONVERSION OFCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS 50-100 MGM		Lindera obtusiloba (LAURACEAE)	OBTUSILACTONE
249101	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lindera obtusiloba (LAURACEAE)	MATAIRESINOL,5-6-DIHYDROXY:
851083	PHYTOCHEMICAL SCREENING FOR		Lindera obtusiloba (LAURACEAE)	OOOOO
776218	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249110	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	MATAIRESINOL,5-6-DIHYDROXY:
261168	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PENTA-2-4-DIEN-4-OLIDE,2-(1-METHOXY-11-DODECENYL):
261179	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,TRANS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHOXY-4-METHYL: (3R-4R):
385241	VOUCHER SPECIMEN REPORTED FOR		Lindera obtusiloba (LAURACEAE)
736694	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
791596	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	CYCLOOXYGENASE INHIBITION	Lindera obtusiloba (LAURACEAE)
249113	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Lindera obtusiloba (LAURACEAE)	LARICIRESINOL,9'-O-TRANS-FERULOYL-5'-DIMETHOXY: (+):
249105	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PLUVIATILOL
736707	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
261178	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,TRANS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHOXY-4-METHYL: (3R-4R):
249121	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	LARICIRESINOL,9'-O-TRANS-FERULOYL-5'-DIMETHOXY: (+):
736698	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249117	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	SYRINGARESINOL,(+):
736701	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
776213	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249106	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PLUVIATILOL
249116	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	SYRINGARESINOL,(+):
261170	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PENTA-2-4-DIEN-4-OLIDE,2-(1-METHOXY-11-DODECENYL):
261181	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,TRANS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHOXY-4-METHYL: (3R-4R):
738468	PHARMACOLOGY OF EXTRACT - IN VITRO	ANGIOGENESIS INHIBITION	Lindera obtusiloba (LAURACEAE)
249096	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	ACTIFOLIN
736710	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249102	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PLUVIATILOL
736703	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
261174	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,CIS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHYL: (3S-4S):
249095	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	ACTIFOLIN
249112	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lindera obtusiloba (LAURACEAE)	SYRINGARESINOL,(+):
776217	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249123	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	LARICIRESINOL,9'-O-TRANS-FERULOYL-5'-DIMETHOXY: (+):
1138773	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Lindera obtusiloba (LAURACEAE)
736706	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
261169	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PENTA-2-4-DIEN-4-OLIDE,2-(1-METHOXY-11-DODECENYL):
385242	PHARMACOLOGY OF EXTRACT - IN VITRO	TYROSINASE INHIBITION	Lindera obtusiloba (LAURACEAE)
261175	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,CIS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHYL: (3S-4S):
738467	VOUCHER SPECIMEN REPORTED FOR		Lindera obtusiloba (LAURACEAE)
776214	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
736695	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
726804	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)
331254	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM		Lindera obtusiloba (LAURACEAE)	OBTUSILACTONE,ISO:OBTUSILACTONE A,ISO:OBTUSILACTONE A
261180	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,TRANS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHOXY-4-METHYL: (3R-4R):
1138772	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Lindera obtusiloba (LAURACEAE)
586420	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)
249107	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	MATAIRESINOL,5-6-DIHYDROXY:
249109	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	MATAIRESINOL,5-6-DIHYDROXY:
249099	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	ACTIFOLIN
736700	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249115	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	SYRINGARESINOL,(+):
249122	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	LARICIRESINOL,9'-O-TRANS-FERULOYL-5'-DIMETHOXY: (+):
736704	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
776211	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
261165	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Lindera obtusiloba (LAURACEAE)	PENTA-2-4-DIEN-4-OLIDE,2-(1-METHOXY-11-DODECENYL):
249103	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	PLUVIATILOL
261173	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,CIS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHYL: (3S-4S):
249094	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Lindera obtusiloba (LAURACEAE)	ACTIFOLIN
776210	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
249111	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	MATAIRESINOL,5-6-DIHYDROXY:
261176	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	BUTANOLIDE,CIS-2-(11-DODECENYLIDENE)-3-HYDROXY-4-METHYL: (3S-4S):
736705	VOUCHER SPECIMEN REPORTED FOR		Lindera obtusiloba (LAURACEAE)
776215	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)
330266	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE		Lindera obtusiloba (LAURACEAE)	OBTUSILACTONE C-17-DIMEROBTUSILACTONE BOBTUSILACTONE B,ISO:
726803	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIADHESION EFFECT	Lindera obtusiloba (LAURACEAE)
249119	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)	LARICIRESINOL,9'-O-TRANS-FERULOYL-5'-DIMETHOXY: (+):
565187	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Lindera obtusiloba (LAURACEAE)
736696	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Lindera obtusiloba (LAURACEAE)

Experiments for taxon Lindera obtusiloba (LAURACEAE)

Experiments (98 results)

Filters

Worktypes (18)

Pharmacology (12)

Compounds (22)

Organisms (24)